» Articles » PMID: 174116

Suppression of Murine Type-C RNA Virogenes by Type-specific Oncornavirus Vaccines: Prospects for Prevention of Cancer

Overview
Specialty Science
Date 1976 Feb 1
PMID 174116
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Immunization of crossbred and F1 mice with combined killed and live Gross leukemia virus AKR type-C viral vaccines suppressed endogeneous N-type AKR virus up to 10,000-fold for significant periods during early life. Since several previous studies in the same and similar crossbred systems revealed direct correlations between low and high levels of type-C virus early in life with low and high incidences of leukemia and other cancers later in life, we believe that prospects for suppression of spontaneous neoplasms are good; however, 8-14 months will be required to achieve the final results. Should cancers be prevented by serotype-specific vaccines, such evidence would provide conclusive proof of endogenous viral etiology.

Citing Articles

Kinetics of expression of infectious ecotropic, xenotropic, and mink cell focus-forming murine leukemia virus after 5-iododeoxyuridine induction of cells from high- and low-leukemia mouse strains.

Rapp U J Virol. 1983; 45(2):755-65.

PMID: 6300432 PMC: 256470. DOI: 10.1128/JVI.45.2.755-765.1983.


Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.

Mayer A, Basombrio M, Pasqualini C Br J Cancer. 1980; 41(6):966-75.

PMID: 6252923 PMC: 2010361. DOI: 10.1038/bjc.1980.175.


Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

Versteegen R, Oroszlan S J Virol. 1980; 33(3):983-92.

PMID: 6154154 PMC: 288632. DOI: 10.1128/JVI.33.3.983-992.1980.


Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.

Genovesi E, Marx P, Wheelock E J Exp Med. 1977; 146(2):520-34.

PMID: 327016 PMC: 2180763. DOI: 10.1084/jem.146.2.520.


Specificity of response to viral proteins in horses infected with equine infectious anemia virus.

Charman H, Long C, COGGINS L Infect Immun. 1979; 23(2):472-8.

PMID: 217831 PMC: 414189. DOI: 10.1128/iai.23.2.472-478.1979.


References
1.
MOLONEY J . Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst. 1960; 24:933-51. View

2.
IGEL H, HUEBNER R, Turner H, Kotin P, FALK H . Mouse leukemia virus activation by chemical carcinogens. Science. 1969; 166(3913):1624-6. DOI: 10.1126/science.166.3913.1624. View

3.
Lilly F, DURAN-REYNALS M, Rowe W . Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med. 1975; 141(4):882-9. PMC: 2189752. View

4.
Hartley J, Rowe W . Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology. 1975; 65(1):128-34. DOI: 10.1016/0042-6822(75)90013-6. View

5.
Levy J, Pincus T . Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science. 1970; 170(3955):326-7. DOI: 10.1126/science.170.3955.326. View